Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company is headquartered in Barcelona, Barcelona and currently employs 2,084 full-time employees. The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Follow-Up Questions
¿Quién es el CEO de Almirall SA?
Mr. Carlos Gallardo Pique es el Executive Chairman of the Board de Almirall SA, se unió a la empresa desde 2014.
¿Qué tal es el rendimiento del precio de la acción LBTSF?
El precio actual de LBTSF es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Almirall SA?
Almirall SA pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Almirall SA?
La capitalización bursátil actual de Almirall SA es $0
¿Es Almirall SA una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 15 analistas han realizado calificaciones de análisis para Almirall SA, incluyendo 3 fuerte compra, 9 compra, 3 mantener, 0 venta, y 3 fuerte venta
